Jonathan Burkett
Chief Operations Officer / MedTech Strategy at TrackableMed- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
TrackableMed
-
United States
-
Advertising Services
-
1 - 100 Employee
-
Chief Operations Officer / MedTech Strategy
-
Sep 2021 - Present
We help you avoid the frustration of lost advertising dollars by transforming your marketing into a scalable model that improves results for both patients and your company.Our clients have achieved outcomes such as:- Doubling the size of their practice in patient volume- Over $500,000/month in procedure reimbursement revenue for specialty practice- Expanding their business model to a national level- Average cost per appointment less than 2% of monthly advertising investment
-
-
Director of MedTech Market Strategy
-
Dec 2020 - Dec 2021
TrackableMed, formerly known as Trackable Lead Generation, is a medical marketing agency and strategic partner for specialty practices, PPMs, and medical companies. With a service model rooted in behavioral science, our team has a proven track record for acquiring new patients, resulting in trackable growth for our clients.
-
-
Director of Accounts and Marketing
-
Jan 2016 - Dec 2020
-
-
-
Acclarent
-
Medical Device
-
100 - 200 Employee
-
Titles held: US Marketing Manager, Key Accounts Manager & ENT Consultant
-
Aug 2008 - Dec 2015
Ear, Nose, and Throat - From the early start-up phase with Acclarent, through several years after Johnson & Johnson's acquisition of Acclarent ($785M). Ear, Nose, and Throat - From the early start-up phase with Acclarent, through several years after Johnson & Johnson's acquisition of Acclarent ($785M).
-
-
-
Hologic, Inc.
-
United States
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
Titles held: District Sales Manager & Territory Manager
-
2001 - Aug 2008
Women's Health - From Novacept's early start-up phase through Cytyc's acquisition of Novacept ($325M), followed by Hologic's acquisition of Cytyc ($6.2B). Women's Health - From Novacept's early start-up phase through Cytyc's acquisition of Novacept ($325M), followed by Hologic's acquisition of Cytyc ($6.2B).
-
-
Education
-
Louisiana State University
BFA, Fine Arts and Graphic Design